MedPath

LEUPROLIDE ACETATE INJECTION

LEUPROLIDE ACETATE INJECTION

Discontinued
DIN Number

02240264

Drug Class

Human

Market Date

N/A

Company
HC

novopharm limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02240264
AIG Number0116959001
Classification & Schedule
C
Drug Class
Human
A
ATC Code
L02AE02 LEUPRORELIN
Product Specifications
Dosage FormLiquid
Route of AdministrationSubcutaneous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

LEUPROLIDE ACETATEActive
Strength: 5 MG / ML
Monograph: LEUPROLIDE ACETATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.